SC 13G/A

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Company: Viridian Therapeutics, Inc.\DE
Filed: February 14, 2022
Accession Number: 0000921895-22-000536

View Document ↗ View on SEC.gov ↗